Abstract
ObjectiveEmerging evidence from observational studies (cohort and case–control studies) suggests that a history of diabetes mellitus (DM) has been linked to increased risk of ovarian cancer (OC), but the association between them remains inconclusive. The aim of this systematic review and meta-analysis of observational studies was to clarify this association.DesignSystematic review and meta-analysis.MethodsWe searched PubMed, Embase and the Cochrane library databases published from the inception through 9 April 2020 without language restriction. Observational studies that evaluated the correlation between DM and the incidence of OC were included in our study. Relative risk (RR) with 95% CI was pooled by use of a random-effects model.ResultsA total of 36 epidemiological articles, including 9 case–control and 27 cohort studies, were finally enrolled, consisting of 14 496 incident cases of OC. Synthesised RRs of developing OC by history of DM were 1.20 (95% CI=1.10 to 1.31) for all eligible studies, 1.08 (95% CI=0.77 to 1.53) for case–control studies and 1.22 (95% CI=1.11 to 1.33) for cohort studies. The above-mentioned positive association persisted across most of subgroup analyses, whereas it was not significant among studies from North American and European countries, level of unadjusted, and patients with low-quality and gestational DM group. The cumulative meta-analysis and sensitivity analysis showed pooled effect was stable and reliable, and no apparent publication bias was identified in this study.ConclusionsOur study found weaker but still association between DM and OC risk. However, further well-designed prospective studies that control for potential confounders are warranted.
Reference78 articles.
1. Systematic review of polygenic risk scores for type 1 and type 2 diabetes;Padilla-Martínez;Int J Mol Sci,2020
2. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus
3. International Diabetes Federation . IDF diabetes atlas. 9th ED. Brussels, Belgium: international diabetes Federation. secondary international diabetes Federation. IDF diabetes atlas. 9th ed. Brussels, Belgium: International Diabetes Federation, 2019. https://diabetesatlas.org/upload/resources/material/20200302_133351_IDFATLAS9e-final-web.pdf
4. Chaperone-Based therapeutic target innovation: heat shock protein 70 (Hsp70) for type 2 diabetes mellitus;Mulyani;Diabetes Metab Syndr Obes,2020
5. Rachdaoui N . Insulin: the Friend and the foe in the development of type 2 diabetes mellitus. Int J Mol Sci 2020;21:1770. doi:10.3390/ijms21051770
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献